The earnings call presented several notable challenges, including a significant revenue decline due to a system transition in Japan and the impact of China's medical cost control policies. However, there were positive developments such as the launch of new products and progress in Alzheimer's testing. Despite these positive aspects, the lowlights indicating declines in revenue and profit suggest a cautious outlook.

Company Guidance -

Q2 2026

In the recent call, Sysmex provided guidance on their Q1 FY2026 financial results, highlighting a significant decline in revenue and operating profit year-over-year due to special one-time factors. Revenue fell by JPY3.3 billion, and operating profit dropped by JPY4.8 billion, primarily due to the transition to a new core system, which led to restricted order intake and a JPY1.7 billion cost of sales adjustment from overseas inventory valuation. While Japan's revenue decreased by approximately 80% YoY due to this transition, other regions like the Americas, EMEA, and AP showed local currency revenue growth. The stronger yen further impacted the results. Notably, Hematology revenue saw a slight decline YoY, while Japan experienced a significant increase of 118.9% when excluding currency effects. Despite these challenges, the company remains optimistic about recovery in H2, driven by its new product launches in the U.S., expansion in its medical robotics business, and growth in the IVD domain. The company also adjusted its H1 forecast, expecting a revenue decrease of JPY12.5 billion to JPY240 billion and an operating profit decrease of JPY8.5 billion to JPY36 billion. They are committed to achieving their full-year targets through strategic initiatives and portfolio expansion.

Strong Revenue Growth in Japan for Coagulation Segment

Revenue increased by JPY1.79 billion, or 112.3% YoY, indicating strong double-digit growth in Japan for the Coagulation segment.

Positive Developments in Alzheimer's Testing

Progress was made with the amyloid-beta testing reagent, which meets the Alzheimer’s Association's guidelines with over 90% sensitivity and specificity.

Successful Launch of New Products in the U.S.

The XR and CN series received U.S. regulatory approval and are expected to drive growth in the largest market.

Growth in Hematology and Urinalysis in North America

Hematology and urinalysis have grown significantly in North America, contributing to a 102.9% increase YoY on a local currency basis for the Americas overall.

Sysmex (SSMXF) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

SSMXF Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 05, 2025	2026 (Q2)	0.18 / -	0.163	―	―	―
Aug 06, 2025	2026 (Q1)	0.12 / 0.05	0.12	-58.73% (-0.07)		―
May 14, 2025	2025 (Q4)	0.16 / 0.12	0.165	-27.08% (-0.04)		―
Feb 12, 2025	2025 (Q3)	0.16 / 0.18	0.133	35.76% (+0.05)		―
Nov 06, 2024	2025 (Q2)	0.15 / 0.16	0.146	11.14% (+0.02)		―
Aug 06, 2024	2025 (Q1)	0.11 / 0.12	0.093	28.81% (+0.03)		―
May 09, 2024	2024 (Q4)	0.17 / 0.16	0.114	43.91% (+0.05)		―
Feb 09, 2024	2024 (Q3)	0.16 / 0.13	0.121	10.05% (+0.01)		―
Nov 08, 2023	2024 (Q2)	0.13 / 0.15	0.172	-15.04% (-0.03)		―
Aug 08, 2023	2024 (Q1)	0.12 / 0.09	0.087	7.35% (<+0.01)		―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

SSMXF Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 06, 2025	$15.30	$15.60	+1.96%
May 14, 2025	$17.25	$17.25	0.00%
Feb 12, 2025	$18.50	$18.18	-1.73%
Nov 06, 2024	$18.28	$18.30	+0.11%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Sysmex Corporation (SSMXF) report earnings?

Sysmex Corporation (SSMXF) is schdueled to report earning on Nov 05, 2025, TBA (Confirmed).

What is Sysmex Corporation (SSMXF) earnings time?

Sysmex Corporation (SSMXF) earnings time is at Nov 05, 2025, TBA (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is SSMXF EPS forecast?

SSMXF EPS forecast for the fiscal quarter 2026 (Q2) is 0.18.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing